On the other side, MHC-II molecules, the restricting element for CD4+ TH cell recognition, were detected in a relevant amount of tumor cells (at least 10%) only in 10 patients of the recruited population (i.e., 43.5%). The gene discussed is CD4; the disease is neoplasm.